Literature DB >> 27305932

Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism.

Marta Crous-Bou, Immaculata De Vivo, Carlos A Camargo, Raphaëlle Varraso, Francine Grodstein, Majken K Jensen, Peter Kraft, Samuel Z Goldhaber, Sara Lindström, Christopher Kabrhel1.   

Abstract

Multiple genetic and environmental risk factors contribute to venous thromboembolism (VTE) risk. Understanding how genes and environmental risk factors interact may provide key insight into the pathophysiology of VTE and may identify opportunities for targeted prevention and treatment. It was our aim to examine the main effects and the potential effect-modification between single nucleotide polymorphisms (SNPs) at established loci and lifestyle risk factors for VTE. We performed a nested case-control study using data on 1,040 incident VTE cases and 16,936 controls from the Nurses' Health Study, Nurses' Health Study II, and Health Professionals Follow-up Study cohorts, who gave blood, were selected as participants in a previous genome-wide association study (GWAS), and completed a biennial questionnaire at time of blood draw. We selected SNPs that were associated with VTE risk in previous GWAS studies. A genetic risk score (GRS) was constructed to evaluate the combined effect of the 16 SNPs that have reached genome-wide significance in previous GWAS of VTE. Interactions between SNPs and VTE risk factors (BMI and smoking) were also assessed. We found a significant association between our GRS and VTE risk. The risk of VTE among individuals in the highest GRS tertile was 2.02 times that of individuals in the lowest GRS tertile (p-trend = 9.69×10(-19)). The OR was 1.52 (p=1.03×10(-8)) for participants in the highest GRS tertile compared to those in the medium GRS tertile. However, while BMI and smoking were associated with VTE, and their effects were additive to each other we did not observe any significant multiplicative gene-environment interactions.

Entities:  

Keywords:  Body mass index; gene-environment interactions; genetic susceptibility; smoking; venous thromboembolism

Mesh:

Year:  2016        PMID: 27305932      PMCID: PMC5177985          DOI: 10.1160/TH16-02-0172

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  38 in total

1.  Genetic determinants of hemostasis phenotypes in Spanish families.

Authors:  J C Souto; L Almasy; M Borrell; M Garí; E Martínez; J Mateo; W H Stone; J Blangero; J Fontcuberta
Journal:  Circulation       Date:  2000-04-04       Impact factor: 29.690

2.  A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.

Authors:  Weihong Tang; Martina Teichert; Daniel I Chasman; John A Heit; Pierre-Emmanuel Morange; Guo Li; Bruno H Ch Stricker; Paul M Ridker; Aaron R Folsom; Nicholas L Smith; Nathan Pankratz; Frank W Leebeek; Guillaume Paré; Mariza de Andrade; Christophe Tzourio; Bruce M Psaty; Saonli Basu; Rikje Ruiter; Lynda Rose; Sebastian M Armasu; Thomas Lumley; Susan R Heckbert; André G Uitterlinden; Mark Lathrop; Kenneth M Rice; Mary Cushman; Albert Hofman; Jean-Charles Lambert; Nicole L Glazer; James S Pankow; Jacqueline C Witteman; Philippe Amouyel; Joshua C Bis; Edwin G Bovill; Xiaoxiao Kong; Russell P Tracy; Eric Boerwinkle; Jerome I Rotter; David-Alexandre Trégouët; Daan W Loth
Journal:  Genet Epidemiol       Date:  2013-05-05       Impact factor: 2.135

Review 3.  Epidemiology and risk factors of venous thromboembolism.

Authors:  Walter Ageno; Alessandro Squizzato; David Garcia; Davide Imberti
Journal:  Semin Thromb Hemost       Date:  2006-10       Impact factor: 4.180

Review 4.  The Nurses' Health Study: lifestyle and health among women.

Authors:  Graham A Colditz; Susan E Hankinson
Journal:  Nat Rev Cancer       Date:  2005-05       Impact factor: 60.716

5.  Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT).

Authors:  C Y Vossen; J Conard; J Fontcuberta; M Makris; F J M VAN DER Meer; I Pabinger; G Palareti; F E Preston; I Scharrer; J C Souto; P Svensson; I D Walker; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2005-03       Impact factor: 5.824

Review 6.  Venous thrombosis: a multicausal disease.

Authors:  F R Rosendaal
Journal:  Lancet       Date:  1999-04-03       Impact factor: 79.321

7.  Familial segregation of venous thromboembolism.

Authors:  J A Heit; M A Phelps; S A Ward; J P Slusser; T M Petterson; M De Andrade
Journal:  J Thromb Haemost       Date:  2004-05       Impact factor: 5.824

8.  Body mass index and risk of prostate cancer in U.S. health professionals.

Authors:  Edward Giovannucci; Eric B Rimm; Yan Liu; Michael Leitzmann; Kana Wu; Meir J Stampfer; Walter C Willett
Journal:  J Natl Cancer Inst       Date:  2003-08-20       Impact factor: 13.506

9.  A prospective study of cruciferous vegetables and prostate cancer.

Authors:  Edward Giovannucci; Eric B Rimm; Yan Liu; Meir J Stampfer; Walter C Willett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-12       Impact factor: 4.254

10.  Multilocus genetic risk scores for venous thromboembolism risk assessment.

Authors:  José Manuel Soria; Pierre-Emmanuel Morange; Joan Vila; Juan Carlos Souto; Manel Moyano; David-Alexandre Trégouët; José Mateo; Noémi Saut; Eduardo Salas; Roberto Elosua
Journal:  J Am Heart Assoc       Date:  2014-10-23       Impact factor: 5.501

View more
  2 in total

Review 1.  Environmental and Genetic Risk Factors Associated with Venous Thromboembolism.

Authors:  Marta Crous-Bou; Laura B Harrington; Christopher Kabrhel
Journal:  Semin Thromb Hemost       Date:  2016-10-20       Impact factor: 4.180

Review 2.  Thrombophilia screening revisited: an issue of personalized medicine.

Authors:  Giuseppe Colucci; Dimitrios A Tsakiris
Journal:  J Thromb Thrombolysis       Date:  2020-05       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.